ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 186 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $1,574,000 | -36.2% | 381,089 | +25.2% | 0.00% | -33.3% |
Q3 2016 | $2,466,000 | +72.0% | 304,452 | +65.6% | 0.00% | +200.0% |
Q2 2016 | $1,434,000 | +77.9% | 183,836 | +76.1% | 0.00% | 0.0% |
Q1 2016 | $806,000 | -20.6% | 104,397 | +11.0% | 0.00% | 0.0% |
Q4 2015 | $1,015,000 | +72.0% | 94,077 | +10.2% | 0.00% | 0.0% |
Q3 2015 | $590,000 | -31.5% | 85,370 | -12.2% | 0.00% | 0.0% |
Q2 2015 | $861,000 | +26.4% | 97,217 | +40.7% | 0.00% | 0.0% |
Q1 2015 | $681,000 | +7.1% | 69,115 | +33.2% | 0.00% | 0.0% |
Q4 2014 | $636,000 | -72.6% | 51,879 | -77.7% | 0.00% | -50.0% |
Q3 2014 | $2,321,000 | +133.0% | 232,588 | +76.7% | 0.00% | +100.0% |
Q2 2014 | $996,000 | -25.1% | 131,633 | -67.4% | 0.00% | 0.0% |
Q1 2014 | $1,330,000 | -36.9% | 404,207 | -36.4% | 0.00% | -50.0% |
Q4 2013 | $2,109,000 | -0.3% | 635,534 | -9.3% | 0.00% | 0.0% |
Q3 2013 | $2,116,000 | -78.0% | 700,677 | -40.5% | 0.00% | -80.0% |
Q2 2013 | $9,637,000 | – | 1,178,147 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|